Clinical Trial Update: Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing BEGEDINA with conventional treatment for steroid-resistant acute graft-versus-host disease was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• BEGEDINA

Snippet

Sponsor: Adienne SA | Conditions: Graft vs Host Disease | Phase 3 | Status: TERMINATED | Results posted: 2020-01-30